But most studies and companies focus on one or the other, which has created some friction in the NAD+ boosting community, between advocates of NMN and advocates of NR
The Motion to Dismiss had been filed by the defendants in January, 2025, who argued that the plaintiffs had failed to present valid claims, which would require the court to dismiss all except those alleging the companies failure to warn about the risks of gastrointestinal issues
The COA should verify peptide identity, purity (typically 98%+ for research-grade), and absence of contaminants including endotoxins, heavy metals, and residual solvents
While average plasma glutathione levels were slightly higher with SAG, erythrocyte glutathione levels were somewhat lower compared to regular glutathione (Cavallaro et al., Int J Clin Nutr Diet, 2018) [17]
Cagini, C., Leontiadis, A., Ricci, M
Compounded semaglutide became widely available during the FDA-documented Wegovy shortage (2022 to late 2024)
